Abstract
High-throughput, accurate, cost-effective and rapid testing for severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) is the need of the hour in face of the global coronavirus disease pandemic. This target is achievable, within a relatively short time through capacity building of reverse transcription polymerase chain reaction (RT-PCR) tests by utilising the strengths of intra and inter institutional networks. These networks act as force multiplier for vital resources which are required for capacity building, namely, leadership, expertise, equipment, space, infection control inputs and human resources. In this article, we report the experience of capacity building for delivery of RT-PCR tests for SARS CoV-2 from a cancer hospital in Eastern India. The relevance, mode of operation and value addition of this essential public health service are discussed in the context of inter departmental collaboration and interaction with other institutes through the existing diagnostic, surveillance and infection control networks. This networking model for service development and delivery could be used by other centres.
Keywords: Capacity building, coronavirus disease, equipment, human resource, networks, reverse transcription polymerase chain reaction, severe acute respiratory syndrome coronavirus 2
References
- 1.Ministry of Health and Family Welfare, Government of India. Available from: https://www.mohfw.gov.in/. [Last accessed on 2020 Jun 05].
- 2.Health and Family Welfare Department, Government of West Bengal. Available from: https://www.wbhealth.gov.in/. [Last accessed on 2020 Jun 05].
- 3.Indian Council of Medical Research. Available from: https://www.icmr.gov.in/. [Last accessed on 2020 Jun 05].
- 4.The Press Information Bureau BULLETIN ON COVID-19. Posted On: 19 May 2020 6:34PM by PIB Delhi. Available from: https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1625157. [Last accessed on 2020 Jun 05].
- 5.Reusken CB, Broberg EK, Haagmans B, Meijer A, Corman VM, Papa A. Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020. Euro Surveill. 2020;25:2000082. doi: 10.2807/1560-7917.ES.2020.25.6.2000082. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25:2000045. doi: 10.2807/1560-7917.ES.2020.25.3.2000045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Konrad R, Eberle U, Dangel A, Treis B, Berger A, Bengs K. Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020. Euro Surveill. 2020;25:2000173. doi: 10.2807/1560-7917.ES.2020.25.9.2000173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Carter LJ, Garner LV, Smoot JW, Li Y, Zhou Q, Saveson CJ. Assay techniques and test development for COVID-19 diagnosis. ACS Cent Sci. 2020;6:591–605. doi: 10.1021/acscentsci.0c00501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Peter T, Keita MS, Nkengasong J. Building laboratory capacity to combat disease outbreaks in Africa. Afr J Lab Med. 2016;5:579. doi: 10.4102/ajlm.v5i3.579. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Phommasack B, Moen A, Vongphrachanh P, Tsuyuoka R, Cox N, Khamphaphongphanh B. Capacity building in response to pandemic influenza threats: Lao PDR case study. Am J Trop Med Hyg. 2012;87:965–971. doi: 10.4269/ajtmh.2012.12-0074. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Masanza MM, Nqobile N, Mukanga D, Gitta SN. Laboratory capacity building for the International Health Regulations (IHR[2005]) in resource-poor countries: The experience of the African Field Epidemiology Network (AFENET) BMC Public Health. 2010;10(Suppl 1):S8. doi: 10.1186/1471-2458-10-S1-S8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Gupta N, Bhatnagar T, Rade K, Murhekar M, Gangakhedkar RR, Nagar A. Strategic planning to augment the testing capacity for COVID-19 in India. Indian J Med Res. 2020;151:210–215. doi: 10.4103/ijmr.IJMR_1166_20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Mourya DT, Sapkal G, Yadav PD, M Belani SK, Shete A, Gupta N. Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis. Indian J Med Res. 2020;151:172–176. doi: 10.4103/ijmr.IJMR_763_20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Total Operational (Initiated Independent Testing) Laboratories Reporting to ICMR. Available from: https://www.icmr.gov.in/pdf/covid/labs/COVID_Testing_Labs_19052020.pdf. [Last accessed on 2020 Jun 05].
- 15.Albetkova A, Isadore J, Ridderhof J, Ned-Sykes R, Maryogo-Robinson L, Blank E. Critical gaps in laboratory leadership to meet global health security goals. Bull World Health Organ. 2017;95:547. doi: 10.2471/BLT.17.195883. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Inal TC, Goruroglu Ozturk O, Kibar F, Cetiner S, Matyar S, Daglioglu G. Lean six sigma methodologies improve clinical laboratory efficiency and reduce turnaround times. J Clin Lab Anal. 2018;32:e22180. doi: 10.1002/jcla.22180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Samuel L, Novak-Weekley S. The role of the clinical laboratory in the future of health care: Lean microbiology. J Clin Microbiol. 2014;52:1812–1817. doi: 10.1128/JCM.00099-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Establishment of a Network of Laboratories for Managing Epidemics and Natural Calamities (VRDL). Available from: https://dhr.gov.in/schemes/establishment-network-laboratories-managing-epidemics-and-natural-calamities. [Last accessed on 2020 Jun 05].
- 19.Whitaker B, Alroy KA, Guthrie E, Schildecker S, Hiers S, Woodard J. Strengthening laboratory capacity for detection of respiratory viral pathogens through the Global Health Security Agenda (GHSA) framework. Afr J Lab Med. 2019;8:861. doi: 10.4102/ajlm.v8i1.861. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Bhattacharya S. Improving Diagnostic and Laboratory Capacity Helps in Control of Infection: an Indian Perspective. Curr Treat Options Infect Dis. 2020;12:112–121. [Google Scholar]
- 21.ICMR/AIIMS/CDC Global Health Security Agenda Collaborative Project: Capacity Building and Strengthening of Hospital Infection Control to Detect and Prevent Antimicrobial Resistance in India. Available from: http://iamrsn.icmr.org.in/old/index.php/icmr-aiims-cdc-global-health-security-agenda-collaborative-project. [Last accessed on 2020 Jun 05].